CD163 and neoplasm: The main objective of this study was to investigate the relationship between the expression levels of Trop-2, CD47, and CD163, as assessed by immunohistochemistry in tumor tissue, and clinical outcomes and survival in TNBC, which is characterized by an aggressive clinical course and poor prognosis.